Fusion Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.63
|
|
Average Rating
|
4.90
|
|
# Strong Buys
|
9
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.50
|
-0.55
|
-0.05
|
-10.00%
|
|
2022-06-30
|
-0.53
|
-0.44
|
0.09
|
16.98%
|
|
2022-03-31
|
-0.48
|
-0.46
|
0.02
|
4.17%
|
|
2021-12-31
|
-0.47
|
-0.40
|
0.07
|
14.89%
|
|
2021-09-30
|
-0.60
|
-0.45
|
0.15
|
25.00%
|
|
2021-06-30
|
-0.39
|
-0.63
|
-0.24
|
-61.54%
|
|
2021-03-31
|
-0.29
|
-0.42
|
-0.13
|
-44.83%
|
|
2020-12-31
|
-0.19
|
-0.32
|
-0.13
|
-68.42%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.45
|
|
2021-12-31
|
-1.90
|
|
2020-12-31
|
-19.76
|